Table 2.
Characteristics | Frequency (%) (N = 12) |
---|---|
Sex | |
Male | 10 (83.3) |
Female | 2 (16.7) |
Race | |
White | 11 (91.7) |
Black or African American | 1 (8.3) |
Marital status | |
Single/windowed/other | 5 (41.7) |
Married/living with a partner | 7 (58.3) |
Employment status | |
Employed | 6 (50.0) |
Unemployed/other | 6 (50.0) |
Education | |
≥12th grade | 12 (100.0) |
Annual household income | |
Up to $30 000 | 1 (8.3) |
$30 001-60 000 | 1 (8.3) |
Over $60 000 | 8 (66.7) |
Do not care to respond | 2 (16.7) |
Primary tumor location | |
Nasal cavity | 1 (8.3) |
Oral cavity | 3 (25.0) |
Oropharynx | 6 (50.0) |
Hypopharynx | 1 (8.3) |
Salivary gland and other | 1 (8.3) |
Tumor stage (TNM) at diagnosis | |
Stage I | 1 (8.3) |
Stage II | 2 (16.7) |
Stage III | 3 (25.0) |
Stage IV | 5 (41.7) |
Could not be staged | 1 (8.3) |
Charateristic of neck dissection (ND) | |
ND with preservation of jugular vein | 12 (100.0) |
Neck dissection location | |
Unilateral ND | 9 (75.0) |
Bilateral ND | 3 (25.0) |
Complete cancer treatment received | |
Surgery and radiation | 10 (83.3) |
Surgery and CCR | 2 (16.7) |
Characteristic | Median (min, max) |
Age (y) | 58.4 (32, 75) |
Time since HNC treatment ended (mo) | 12.6 (3.5, 16.5) |
Time since diagnosis of lymphedema (mo) | 9.3 (3.0, 15.2) |
Abbreviations: CCR, concurrent chemoradiation; ND, neck dissection.